(NASDAQ: KMDA) Kamada's forecast annual revenue growth rate of 12.19% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.62%.
Kamada's revenue in 2026 is $180,460,000.On average, 6 Wall Street analysts forecast KMDA's revenue for 2026 to be $11,860,829,974, with the lowest KMDA revenue forecast at $11,361,845,590, and the highest KMDA revenue forecast at $12,268,093,530. On average, 5 Wall Street analysts forecast KMDA's revenue for 2027 to be $13,027,818,887, with the lowest KMDA revenue forecast at $12,114,648,621, and the highest KMDA revenue forecast at $13,832,539,368.
In 2028, KMDA is forecast to generate $14,419,206,558 in revenue, with the lowest revenue forecast at $13,592,565,375 and the highest revenue forecast at $15,122,976,441.